Our Team
Lars Hanan
email
301.358.2693
Lars Hanan is co-founder and Managing Partner at BroadOak. With 20 years of corporate finance and mergers and acquisitions experience, Lars Hanan has executed over 100 transactions in a broad range of industries. Prior to BroadOak, Lars built and managed the life scieces advisory business at Mercator Capital. Before joining Mercator Lars headed the M&A Group at ABN AMRO Investment Banking. In addition to heading the U.S. M&A Group, Mr. Hanan was also a member of the firm’s Fairness Opinion Committees and he was also responsible for the firm’s Healthcare M&A practice with particular sector expertise in medical technology and drug discovery tools. Lars was previously Head of Mergers & Acquisitions for SG Cowen’s Media Group managing a wide variety of domestic and cross border transactions. Prior to joining SG Cowen, Lars held senior mergers and acquisitions positions at Kidder, Peabody and Lehman Brothers. Lars currently serves on the boards of Marligen Biosciences, A&G Pharmaceuticals and Noxilizer.
Lars holds a B.A. in Economics from the University of Virginia and an M.B.A. from the J.L. Kellogg School of Management at Northwestern University.
Bill Snider
email
301.358.2694
Bill Snider is co-founder and Managing Partner at BroadOak. Mr. Snider has over 15 years of institutional investment experience. Prior to BroadOak, he was a general partner and co-founder of Emerging Technology Partners, LLC., a life sciences focused venture capital firm. He has invested in over 20 life science companies while at ETP of which more than half were or are now publicly traded. Mr. Snider, at various times, acted as lead investor, board member and chairman for ETP’s portfolio companies. Prior to ETP he was a vice president and portfolio manager at T. Rowe Price. His responsibilities included managing $2 billion of mutual fund and institutional client portfolios. Mr. Snider’s current and past directorships include Alpha Innotech, Atto Biosciences and Marligen Biosciences.
Bill holds the Chartered Financial Analysts accreditation, a B.S. in Finance and an M.B.A. from the Wharton School at the University of Pennsylvania.
Tara St. Amand, Ph.D.
email
301.358.2698
Tara St. Amand is Director of Strategic Alliances at BroadOak. Dr. St. Amand comes to BroadOak from Parker Boston, a private equity investment bank and advisory firm in New York City. At Parker Boston, Tara was a Director responsible for evaluating all investment banking opportunities that came to the firm and was co-lead for multiple transactions in various industries. Prior to Parker Boston, Tara worked as a Postdoctoral Fellow in the Department of Medicine at the University of California, San Diego where her research focus was cardiovascular disease. While in San Diego, Tara had the opportunity to work for a number of local biotechnology companies. She has also worked as business advisor for three biotechnology start-up companies in the New York and Philadelphia areas.
Tara received her B.S. in Biochemistry from the University of Notre Dame, her Ph.D. in Molecular Biology from Tulane University, and her MBA with a concentration in Finance from Columbia University.
Alhassan Bangura, CFA
email
301.358.2695
Alhassan Bangura is a Sr. Associate at BroadOak Capital. With over four years of investment banking experience his transaction experience includes merger and acquisition advisory, financial advisory, valuation and fairness opinions, and private equity offerings. Prior to BroadOak, he was an Associate at Mercator Capital, where he worked on numerous successful corporate finance assignments in the life sciences and communications technology space. Prior to Mercator, he was an Investment Analyst at Golden Rule Insurance Company working primarily on fixed income and asset allocation analysis and manager selection and monitoring.
Alhassan holds a B.S in Economics from Butler University, an M.S in Finance from The Johns Hopkins University and the Chartered Financial Analyst (CFA) accreditation.
Kanishka Pothula
email
301.358.2696
Kanishka Pothula is an Analyst at BroadOak Capital. Prior to BroadOak, he produced research for Bainbridge, Inc. in their Capital Advisory division, covering the life science and oil and gas industries. Prior to joining Bainbridge, he worked as a Research Associate at the University of California's Medical School conducting primary research on apoptotic modeling on T-lymphoma cancer cells. He was also a Research Associate in the cell biology division at Ambit Biosciences in San Diego.
Kanishka holds an M.S. in Biotechnology from Georgetown University and a B.S. in Bioengineering from the University of California, San Diego.